ESR1 and breast cancer: These findings underscore the specificity of MGAT1-mediated CD73 upregulation in TNBC, where immune evasion is driven by high checkpoint expression and adenosine-mediated suppression, whereas ER + breast cancers employ distinct, non-CD73-dependent immune escape mechanisms.